Artiva Biotherapeutics Statistics
Total Valuation
ARTV has a market cap or net worth of $82.47 million. The enterprise value is -$28.81 million.
Important Dates
The last earnings date was Wednesday, November 12, 2025, before market open.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARTV has 24.54 million shares outstanding. The number of shares has increased by 354.77% in one year.
| Current Share Class | 24.54M |
| Shares Outstanding | 24.54M |
| Shares Change (YoY) | +354.77% |
| Shares Change (QoQ) | +0.42% |
| Owned by Insiders (%) | 2.20% |
| Owned by Institutions (%) | 17.96% |
| Float | 5.62M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.65, with a Debt / Equity ratio of 0.09.
| Current Ratio | 11.65 |
| Quick Ratio | 11.14 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -47.96% and return on invested capital (ROIC) is -30.17%.
| Return on Equity (ROE) | -47.96% |
| Return on Assets (ROA) | -28.76% |
| Return on Invested Capital (ROIC) | -30.17% |
| Return on Capital Employed (ROCE) | -62.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$889,753 |
| Employee Count | 89 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.58% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -73.58% |
| 50-Day Moving Average | 3.60 |
| 200-Day Moving Average | 2.96 |
| Relative Strength Index (RSI) | 47.01 |
| Average Volume (20 Days) | 159,052 |
Short Selling Information
The latest short interest is 221,279, so 0.90% of the outstanding shares have been sold short.
| Short Interest | 221,279 |
| Short Previous Month | 256,977 |
| Short % of Shares Out | 0.90% |
| Short % of Float | 3.94% |
| Short Ratio (days to cover) | 0.06 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -86.15M |
| Pretax Income | -79.19M |
| Net Income | -79.19M |
| EBITDA | -83.60M |
| EBIT | -86.15M |
| Earnings Per Share (EPS) | -$3.25 |
Full Income Statement Balance Sheet
The company has $122.97 million in cash and $11.69 million in debt, giving a net cash position of $111.28 million or $4.53 per share.
| Cash & Cash Equivalents | 122.97M |
| Total Debt | 11.69M |
| Net Cash | 111.28M |
| Net Cash Per Share | $4.53 |
| Equity (Book Value) | 129.22M |
| Book Value Per Share | 5.26 |
| Working Capital | 118.41M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$76.68 million and capital expenditures -$2.23 million, giving a free cash flow of -$78.91 million.
| Operating Cash Flow | -76.68M |
| Capital Expenditures | -2.23M |
| Free Cash Flow | -78.91M |
| FCF Per Share | -$3.21 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ARTV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -354.77% |
| Shareholder Yield | -354.77% |
| Earnings Yield | -96.02% |
| FCF Yield | -95.68% |
Analyst Forecast
The average price target for ARTV is $19.20, which is 471.43% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.20 |
| Price Target Difference | 471.43% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 190.13% |
| EPS Growth Forecast (5Y) | -27.31% |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARTV has an Altman Z-Score of 0.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.27 |
| Piotroski F-Score | 2 |